Literature DB >> 21335288

Interventions in the chest in children.

Derek J Roebuck1, Mark J Hogan, Bairbre Connolly, Clare A McLaren.   

Abstract

The scope for image-guided intervention in the chest is very wide and encompasses procedures in the heart, pulmonary and systemic vasculature, lungs and pleural cavities, airway, and esophagus. This review describes the most important procedures that are usually performed by radiologists. Percutaneous drainage is now the most common method of treating both empyemas and lung abscesses in children. Although most lung biopsies are carried out by other means, percutaneous biopsy and localization are important alternatives for the diagnosis of focal lung lesions. Esophageal strictures are common in children and are usually best treated by balloon dilatation. The use of retrievable or biodegradable stents has recently been introduced for refractory esophageal strictures. Similarly, balloon dilatation and stenting are now increasingly used in children with stenosis or extrinsic compression of the trachea or bronchi.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21335288     DOI: 10.1053/j.tvir.2010.07.004

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  2 in total

Review 1.  Paediatric interventional oncology.

Authors:  D J Roebuck
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

2.  Tracheal Replacement Therapy with a Stem Cell-Seeded Graft: Lessons from Compassionate Use Application of a GMP-Compliant Tissue-Engineered Medicine.

Authors:  Martin J Elliott; Colin R Butler; Aikaterini Varanou-Jenkins; Leanne Partington; Carla Carvalho; Edward Samuel; Claire Crowley; Peggy Lange; Nicholas J Hamilton; Robert E Hynds; Tahera Ansari; Paul Sibbons; Anja Fierens; Claire McLaren; Derek Roebuck; Colin Wallis; Nagarajan Muthialu; Richard Hewitt; David Crabbe; Sam M Janes; Paolo De Coppi; Mark W Lowdell; Martin A Birchall
Journal:  Stem Cells Transl Med       Date:  2017-06       Impact factor: 6.940

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.